Castrén, Maija L.

Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover proliferation, and survival in the adult dentate gyrus

Sairanen, M., Lucas, G., Ernfors, P., Castrén, M., & Castrén, E. (2005) · The Journal of Neuroscience

Neurogenesis and neuroplasticity mechanismsNerve injury and regeneration

Cited by 763

Altered differentiation of neural stem cells in fragile X syndrome

Castrén, M., Tervonen, T., Kärkkäinen, V., Heinonen, S., Castrén, E., Larsson, K., Bakker, C. E., Oostra, B. A., & Åkerman, K. (2005) · Proceedings of the National Academy of Sciences

Genetics and Neurodevelopmental DisordersNeurogenesis and neuroplasticity mechanisms

Cited by 176

Augmentation of auditory N1 in children with fragile X syndrome.

Castrén, M., Pääkkönen, A., Tarkka, I. M., Ryynänen, M., & Partanen, J. (2003) · Brain Topography

Genetics and Neurodevelopmental DisordersAutism Spectrum Disorder Research

Cited by 123

Aberrant differentiation of glutamatergic cells in neocortex of mouse model for fragile X syndrome.

Tervonen, T. A., Louhivuori, V., Sun, X., Hokkanen, M.-E., Kratochwil, C. F., Zebryk, P., Castrén, E., & Castrén, M. L. (2009) · Neurobiology of Disease

Genetics and Neurodevelopmental DisordersNeurogenesis and neuroplasticity mechanisms

Cited by 82

Integrative analysis identifies key molecular signatures underlying neurodevelopmental deficits in fragile X syndrome.

Utami, K. H., Skotte, N. H., Colaço, A. R., Yusof, N. A. B. M., Sim, B., Yeo, X. Y., Bae, H.-G., Garcia-Miralles, M., Radulescu, C. I., Chen, Q., et al. (2020) · Biological Psychiatry

Genetics and Neurodevelopmental DisordersAutism Spectrum Disorder Research

Cited by 47

Cortical neurogenesis in fragile X syndrome

Castrén, M. L. (2016) · Frontiers in Bioscience

Genetics and Neurodevelopmental DisordersNeurogenesis and neuroplasticity mechanisms

Cited by 24

Tissue Plasminogen Activator Contributes to Alterations of Neuronal Migration and Activity-Dependent Responses in Fragile X Mice

Achuta, V. S., Rezov, V., Uutela, M., Louhivuori, V., Louhivuori, L., & Castrén, M. L. (2014) · The Journal of Neuroscience

Genetics and Neurodevelopmental DisordersNeurogenesis and neuroplasticity mechanisms

Cited by 22

Urokinase plasminogen activator mediates changes in human astrocytes modeling fragile X syndrome

Peteri, U., Pitkonen, J., de Toma, I., Nieminen, O., Utami, K. H., Strandin, T. M., Corcoran, P., Roybon, L., Vaheri, A., Ethell, I., et al. (2021) · Glia

Genetics and Neurodevelopmental DisordersNeuroscience and Neuropharmacology Research

Cited by 16

An iPSC-derived astrocyte model of fragile X syndrome exhibits dysregulated cholesterol homeostasis

Talvio, K., Wagner, V. A., Minkeviciene, R., Kirkwood, J. S., Kulinich, A. O., Umemori, J., Bhatia, A., Hur, M., Käkelä, R., Ethell, I. M., et al. (2023) · Communications Biology

Genetics and Neurodevelopmental DisordersCholesterol and Lipid Metabolism

Cited by 8

Astrocytes in fragile X syndrome

Talvio, K., & Castrén, M. L. (2024) · Frontiers in Cellular Neuroscience

Genetics and Neurodevelopmental DisordersNeuroscience and Neuropharmacology Research

Cited by 8

Reduced LYNX1 expression in transcriptome of human iPSC-derived neural progenitors modeling fragile X syndrome.

Talvio, K., Minkeviciene, R., Townsley, K. G., Achuta, V. S., Huckins, L. M., Corcoran, P., Brennand, K. J., & Castrén, M. L. (2022) · Frontiers in Cell and Developmental Biology

Genetics and Neurodevelopmental DisordersPluripotent Stem Cells Research

Cited by 5